Get the Stockscreener App
4.68
0.43%
-0.02
After Hours:
4.78
0.10
+2.14%
Lipocine Inc Stock (LPCN) Forecast
The Lipocine Inc (LPCN) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $4.3723, representing a -6.58% decrease from the current price of $4.68. The highest analyst price target is $8.4906, and the lowest is $0.2539.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month LPCN Price Target
Average 16.73
(+257.53% Upside)
Is Lipocine Inc (LPCN) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 46.77 | Neutral |
| STOCH(9,6) | 29.94 | Neutral |
| STOCHRSI(14) | 30.18 | Neutral |
| MACD(12,26) | -0.0463 | Sell |
| ADX(14) | 16.44 | Neutral |
| William %R | -75.22 | Neutral |
| CCI(14) | -26.44 | Neutral |
Buy: 0
Sell: 1
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
4.7098
Sell
|
4.7827
Sell
|
| MA20 |
5.1501
Sell
|
4.874
Sell
|
| MA50 |
4.6258
Buy
|
4.6552
Buy
|
| MA100 |
4.0349
Buy
|
4.2865
Buy
|
| MA200 |
3.7145
Buy
|
4.4265
Buy
|
Buy: 6
Sell: 4
Neutral: 0
Summary: Buy
According to our latest analysis, LPCN could be considered a Neutral, with 17 technical analysis indicators signaling 6 Buy signals, 5 signaling Sell signals and 6 Neutral signals. This suggests that investors should exercise caution when entering new positions on LPCN, as the market is likely to remain volatile in the near term.
- RSI (Relative Strength Index): The RSI(14) value of 46.77 indicates that LPCN is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 29.94 indicates that LPCN is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 30.18 indicates that LPCN is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 16.44 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -26.44 indicates that LPCN is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term LPCN price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Lipocine Inc financial reports and earnings history, Lipocine Inc (LPCN) stock could reach $26.15 by 2030, $21.12 by 2040 and $48.83 by 2050. See the projected annual prices until 2050 of the Lipocine Inc stock below:
- Lipocine Inc (LPCN) is expected to reach an average price of $9.7973 in 2035, with a high prediction of $10.34 and a low estimate of $9.8973. This indicates an $109.34% rise from the last recorded price of $4.68.
- Lipocine Inc (LPCN) stock is projected to chart a bullish course in 2040, with an average price target of $21.85, representing an $366.91% surge from its current level. The forecast ranges from a conservative $21.74 to a sky-high $21.12.
- Our analysts predict Lipocine Inc (LPCN) to jump 699.59% by 2045, soaring from $37.46 to an average price of $37.42, potentially reaching $37.11. While $37.46 is the low estimate, the potential upside is significant.
- Lipocine Inc (LPCN) stock is expected to climb by 2050, reaching an average of $42.07, a $799.01% jump from its current level. However, a wide range of estimates exists, with high and low targets of $48.83 and $45.30, respectively, highlighting the market's uncertainty.
Lipocine Inc Stock (LPCN) Year by Year Forecast
Lipocine Inc Stock (LPCN) Price Forecast for 2024
Our forecast for LPCN stock price in 2024 now indicates an average price target of $16.73 with a high forecast of $33.21 and a low forecast of $0.2539. The average prediction reflects an increase of +257.53% from the last recorded price of $4.68.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2024 | $7.9806 | $0.2539 | $8.4906 | +70.53% |
| July, 2024 | $7.3442 | $2.9272 | $8.4741 | +56.93% |
| August, 2024 | $20.40 | $3.0777 | $25.41 | +335.89% |
| September, 2024 | $23.09 | $18.27 | $33.21 | +393.33% |
| October, 2024 | $27.89 | $19.58 | $30.61 | +495.97% |
| November, 2024 | $21.57 | $16.75 | $28.35 | +360.87% |
| December, 2024 | $17.44 | $17.47 | $16.70 | +272.70% |
Lipocine Inc Stock (LPCN) Price Forecast for 2025
Lipocine Inc Stock (LPCN) is expected to reach an average price of $9.9127 in 2025, with a high prediction of $19.75 and a low estimate of $0.0745. This indicates an +111.81% rise from the last recorded price of $4.68.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $16.63 | $17.63 | $17.92 | +255.38% |
| February, 2025 | $15.77 | $15.59 | $14.89 | +236.91% |
| March, 2025 | $14.78 | $15.54 | $15.10 | +215.86% |
| April, 2025 | $14.50 | $14.28 | $15.26 | +209.73% |
| May, 2025 | $12.65 | $14.01 | $14.49 | +170.27% |
| June, 2025 | $8.4299 | $10.55 | $12.66 | +80.13% |
| July, 2025 | $5.1903 | $6.9164 | $5.3947 | +10.90% |
| August, 2025 | $1.4406 | $0.4206 | $4.1606 | -69.22% |
| September, 2025 | $9.9075 | $1.2541 | $12.80 | +111.70% |
| October, 2025 | $1.2811 | $1.4389 | $19.75 | -72.63% |
| November, 2025 | $3.628 | $0.0745 | $7.1213 | -22.48% |
| December, 2025 | $0.4416 | $0.4084 | $6.5014 | -90.56% |
Lipocine Inc Stock (LPCN) Price Forecast for 2026
The predicted value for Lipocine Inc (LPCN) in 2026 is set at an average of $11.18. Estimates vary from a peak of $22.18 to a trough of $0.1783, indicating an +138.86% surge from the present price of $4.68.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $7.3785 | $0.1783 | $9.2485 | +57.66% |
| February, 2026 | $3.9454 | $1.8286 | $9.9886 | -15.70% |
| March, 2026 | $8.5022 | $2.2288 | $11.56 | +81.67% |
| April, 2026 | $11.61 | $9.089 | $22.18 | +147.99% |
| May, 2026 | $10.04 | $2.5793 | $14.29 | +114.59% |
| June, 2026 | $8.1396 | $4.7562 | $10.97 | +73.92% |
| July, 2026 | $4.4432 | $3.5932 | $8.8963 | -5.06% |
| August, 2026 | $5.2601 | $1.0267 | $7.3167 | +12.40% |
| September, 2026 | $6.1537 | $4.5038 | $8.8737 | +31.49% |
| October, 2026 | $6.3756 | $3.2306 | $7.7934 | +36.23% |
| November, 2026 | $5.9175 | $5.5775 | $8.9173 | +26.44% |
| December, 2026 | $2.4761 | $1.4644 | $6.3342 | -47.09% |
Lipocine Inc Stock (LPCN) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Lipocine Inc (LPCN) is $9.2327, with a high forecast of $18.39 and a low forecast of $0.0794. This indicates an +97.28% increase from the last price of $4.68.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $2.273 | $0.8632 | $5.588 | -51.43% |
| February, 2027 | $4.5348 | $1.4011 | $5.3081 | -3.10% |
| March, 2027 | $3.5584 | $1.3276 | $5.1817 | -23.96% |
| April, 2027 | $2.2605 | $1.1504 | $4.4686 | -51.70% |
| May, 2027 | $1.9792 | $0.1142 | $3.4922 | -57.71% |
| June, 2027 | $11.53 | $1.891 | $11.53 | +146.28% |
| July, 2027 | $9.6227 | $8.0927 | $18.39 | +105.61% |
| August, 2027 | $3.422 | $3.1313 | $9.9544 | -26.88% |
| September, 2027 | $1.6449 | $0.1335 | $5.5863 | -64.85% |
| October, 2027 | $1.0746 | $0.1651 | $3.4033 | -77.04% |
| November, 2027 | $0.9412 | $0.6126 | $2.2121 | -79.89% |
| December, 2027 | $0.0141 | $0.0794 | $2.2238 | -99.70% |
Lipocine Inc Stock (LPCN) Price Forecast for 2028
In 2028, Lipocine Inc (LPCN) is projected to reach an average price of $46.53, with a high projection of $92.23 and a low estimate of $0.8378. This indicates an +894.30% rise from the last price of $4.68.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $1.9843 | $1.8727 | $1.4726 | -57.60% |
| February, 2028 | $3.7157 | $2.8991 | $3.0119 | -20.61% |
| March, 2028 | $4.0291 | $3.8255 | $3.6721 | -13.91% |
| April, 2028 | $2.573 | $3.3465 | $3.7331 | -45.02% |
| May, 2028 | $3.3947 | $3.4668 | $2.5978 | -27.46% |
| June, 2028 | $0.8047 | $1.1447 | $3.0477 | -82.81% |
| July, 2028 | $0.6848 | $0.8378 | $0.6513 | -85.37% |
| August, 2028 | $4.0667 | $1.6111 | $1.4249 | -13.10% |
| September, 2028 | $3.5473 | $3.7941 | $3.1158 | -24.20% |
| October, 2028 | $4.5495 | $4.0705 | $3.759 | -2.79% |
| November, 2028 | $3.7968 | $3.8635 | $92.23 | -18.87% |
| December, 2028 | $2.95 | $3.2566 | $3.2401 | -36.97% |
Lipocine Inc Stock (LPCN) Price Forecast for 2029
The 2029 price forecast for Lipocine Inc Stock (LPCN) is $10.44 on average, with a high prediction of $20.81 and a low estimate of $0.0692. This represents an +123.10% increase from the previous price of $4.68.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $2.6364 | $3.1464 | $3.2785 | -43.67% |
| February, 2029 | $3.1495 | $2.6129 | $2.7595 | -32.70% |
| March, 2029 | $3.3526 | $3.3526 | $3.066 | -28.36% |
| April, 2029 | $3.8657 | $3.6959 | $3.7024 | -17.40% |
| May, 2029 | $3.8021 | $3.9488 | $3.9436 | -18.76% |
| June, 2029 | $3.3652 | $3.5652 | $3.5391 | -28.09% |
| July, 2029 | $2.8983 | $3.1751 | $3.1885 | -38.07% |
| August, 2029 | $1.4047 | $1.5797 | $2.5917 | -69.98% |
| September, 2029 | $1.1879 | $1.1546 | $1.13 | -74.62% |
| October, 2029 | $0.5742 | $0.7342 | $0.9311 | -87.73% |
| November, 2029 | $0.9626 | $0.0692 | $2.7659 | -79.43% |
| December, 2029 | $21.85 | $0.1694 | $20.81 | +366.80% |
Lipocine Inc Stock (LPCN) Price Forecast for 2030
Lipocine Inc Stock (LPCN) is expected to reach an average price of $21.76 in 2030, with a high forecast of $41.79 and a low forecast of $1.7309. This signifies an +364.99% surge from the last price of $4.68.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $24.64 | $22.87 | $26.15 | +426.40% |
| February, 2030 | $19.94 | $20.11 | $20.57 | +326.11% |
| March, 2030 | $20.35 | $20.16 | $19.45 | +334.79% |
| April, 2030 | $1.2995 | $6.9843 | $17.81 | -72.23% |
| May, 2030 | $2.8171 | $1.7309 | $8.1126 | -39.81% |
| June, 2030 | $4.0733 | $2.5268 | $5.9732 | -12.96% |
| July, 2030 | $41.66 | $3.0864 | $40.88 | +790.20% |
| August, 2030 | $42.20 | $41.57 | $41.79 | +801.61% |
| September, 2030 | $39.27 | $40.33 | $41.25 | +739.02% |
| October, 2030 | $38.63 | $38.88 | $38.35 | +725.46% |
| November, 2030 | $39.45 | $37.23 | $37.54 | +743.04% |
| December, 2030 | $38.16 | $37.97 | $37.98 | +715.47% |
1.62%
0.15%
Cap:
|
Volume (24h):